SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000863894-19-000014
Filing Date
2019-12-12
Accepted
2019-12-12 12:32:23
Documents
92
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-K veru-20190930x10k.htm 10-K 2122144
2 EX-4.3 veru-20190930xex4_3.htm EX-4.3 32940
3 EX-21 veru-20190930xex21.htm EX-21 6838
4 EX-23.1 veru-20190930xex23_1.htm EX-23.1 4911
5 EX-31.1 veru-20190930xex31_1.htm EX-31.1 15152
6 EX-31.2 veru-20190930xex31_2.htm EX-31.2 15063
7 EX-32.1 veru-20190930xex32_1.htm EX-32.1 10689
  Complete submission text file 0000863894-19-000014.txt   8440005

Data Files

Seq Description Document Type Size
8 EX-101.INS veru-20190930.xml EX-101.INS 1692852
9 EX-101.SCH veru-20190930.xsd EX-101.SCH 70830
10 EX-101.CAL veru-20190930_cal.xml EX-101.CAL 67870
11 EX-101.DEF veru-20190930_def.xml EX-101.DEF 259659
12 EX-101.LAB veru-20190930_lab.xml EX-101.LAB 537462
13 EX-101.PRE veru-20190930_pre.xml EX-101.PRE 463149
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-13602 | Film No.: 191281458
SIC: 2834 Pharmaceutical Preparations